2015 Annual Meeting | 7ES.003 - Multiple Sclerosis Therapy II: Disease-modifying Treatment
01:00 PM - 01:05 PM |
Introduction
Bruce A. Cree, MD, PhD, MAS, FAAN |
|
01:05 PM - 01:55 PM |
Current Therapies: Do We Have Enough Data for a Treatment Algorithm?
Timothy W. West, MD |
|
01:55 PM - 02:45 PM |
PM Risk Stratification
Bruce A. Cree, MD, PhD, MAS, FAAN |
|
02:45 PM - 03:00 PM |
Break
|
|
03:00 PM - 03:50 PM |
Mechanism of Action of Multiple Sclerosis Disease Modifying Therapies
Scott S. Zamvil, MD, PhD, FAAN |
|
03:50 PM - 04:00 PM |
Discussion: Case-based Approach to Treatment
Bruce A. Cree, MD, PhD, MAS, FAAN, Timothy W. West, MD, Scott S. Zamvil, MD, PhD, FAAN |
Bruce A. Cree, MD, PhD, MAS, FAAN | The institution of Dr. Cree has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avotres. The institution of Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Horizon. Dr. Cree has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuron23. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Pharma. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hexal/Sandoz. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Cree has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic AG. The institution of Dr. Cree has received research support from Genentech. The institution of Dr. Cree has received research support from Kyverna. Dr. Cree has received publishing royalties from a publication relating to health care. |
Timothy W. West, MD | Dr. West has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. West has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD serono. Dr. West has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genzyme. |
Scott S. Zamvil, MD, PhD, FAAN | Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Zamvil has received research support from Sumaira Foundation. Dr. Zamvil has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion. |